Immediate Impact
79 standout
Citing Papers
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
2024 Standout
Works of Michael W. Freckleton being referenced
Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael W. Freckleton | 93 | 116 | 5 | 216 | 151 | 8 | 438 | |
| Alessandro Di Lelio | 63 | 98 | 1 | 218 | 213 | 11 | 433 | |
| Fiona Cassidy | 59 | 190 | 1 | 155 | 97 | 14 | 432 | |
| Theodore Gleason | 32 | 93 | 3 | 258 | 116 | 5 | 426 | |
| Arash Anvari | 77 | 111 | 7 | 92 | 44 | 15 | 504 | |
| V. Ladam-Marcus | 153 | 186 | 2 | 86 | 33 | 14 | 473 | |
| Ja Youn Lee | 68 | 195 | 5 | 78 | 46 | 13 | 431 | |
| Diamond Joy | 15 | 60 | 314 | 125 | 8 | 394 | ||
| Hugo W. de Jong | 50 | 58 | 3 | 132 | 35 | 14 | 390 | |
| Yongping Lu | 64 | 46 | 71 | 128 | 133 | 9 | 405 | |
| DK Heaston | 151 | 195 | 4 | 59 | 67 | 9 | 470 |
All Works
Loading papers...